Cargando…

Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study

INTRODUCTION: Both myasthenia gravis (MG) and autoimmune thyroid diseases (AITDs) are autoimmune diseases. Graves’disease (GD) is the most common AITD reported to be associated with MG. Currently, there is limited data on prevalence and clinical features/outcomes of MG in various thyroid diseases in...

Descripción completa

Detalles Bibliográficos
Autores principales: Virameteekul, Sasivimol, Charoensri, Suranut, Sawanyawisuth, Kittisak, Tiamkao, Somsak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the ASEAN Federation of Endocrine Societies 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784156/
https://www.ncbi.nlm.nih.gov/pubmed/33442150
http://dx.doi.org/10.15605/jafes.034.02.05
_version_ 1783632249759989760
author Virameteekul, Sasivimol
Charoensri, Suranut
Sawanyawisuth, Kittisak
Tiamkao, Somsak
author_facet Virameteekul, Sasivimol
Charoensri, Suranut
Sawanyawisuth, Kittisak
Tiamkao, Somsak
author_sort Virameteekul, Sasivimol
collection PubMed
description INTRODUCTION: Both myasthenia gravis (MG) and autoimmune thyroid diseases (AITDs) are autoimmune diseases. Graves’disease (GD) is the most common AITD reported to be associated with MG. Currently, there is limited data on prevalence and clinical features/outcomes of MG in various thyroid diseases in a large database report. METHODOLOGY: A total of 872 patients with MG and 97,251 patients with thyroid disorders had been recorded by the tertiary hospital database. The study period was between 1997 and 2017. Patients with a thyroid disorder and MG were identified by the ICD-10-CM code. Clinical courses of MG accompanied by thyroid disorders were studied. RESULTS: During the 20-year study period, there were 872 patients with MG and 97,251 patients with thyroid disorders. In the group with thyroid disorders, 28,886 patients (29.70%) had GD, 1,612 patients (1.66%) had Hashimoto's thyroiditis (HT), 13,172 patients (13.54%) had toxic goiter and 53,581 patients (55.10%) had nontoxic goiter. Ninety-seven patients had been diagnosed with both MG and thyroid disorders. Among the four types of thyroid disorders, the rate of MG was highest in HT group (9.92/1,000 HT patients). There were four significant factors among four groups of thyroid disorders including age of onset of thyroid disease (p 0.004), MG classification (p<0.001), MG treatment (p<0.001), and thymic pathology (p 0.034). Among the four groups of thyroid disorders, patients with MG and HT were diagnosed with thyroid disease at the youngest age (27 years) compared with other thyroid diseases. Additionally, the MG patients with HT also had the highest proportion of MG class 4-5 a/b (7 patients, 43.75%), received prednisolone treatment (15 patients, 93.75%), received immunosuppressants (9 patients, 56.25%), received IVIG or PLEX (5 patients, 31.30%), and had thymoma (6 patients, 46.15%). CONCLUSION: MG is most prevalent in patients with HT. Patients with both MG and HT had more severe MG status and had higher rate of thymoma.
format Online
Article
Text
id pubmed-7784156
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Journal of the ASEAN Federation of Endocrine Societies
record_format MEDLINE/PubMed
spelling pubmed-77841562021-01-12 Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study Virameteekul, Sasivimol Charoensri, Suranut Sawanyawisuth, Kittisak Tiamkao, Somsak J ASEAN Fed Endocr Soc Original Article INTRODUCTION: Both myasthenia gravis (MG) and autoimmune thyroid diseases (AITDs) are autoimmune diseases. Graves’disease (GD) is the most common AITD reported to be associated with MG. Currently, there is limited data on prevalence and clinical features/outcomes of MG in various thyroid diseases in a large database report. METHODOLOGY: A total of 872 patients with MG and 97,251 patients with thyroid disorders had been recorded by the tertiary hospital database. The study period was between 1997 and 2017. Patients with a thyroid disorder and MG were identified by the ICD-10-CM code. Clinical courses of MG accompanied by thyroid disorders were studied. RESULTS: During the 20-year study period, there were 872 patients with MG and 97,251 patients with thyroid disorders. In the group with thyroid disorders, 28,886 patients (29.70%) had GD, 1,612 patients (1.66%) had Hashimoto's thyroiditis (HT), 13,172 patients (13.54%) had toxic goiter and 53,581 patients (55.10%) had nontoxic goiter. Ninety-seven patients had been diagnosed with both MG and thyroid disorders. Among the four types of thyroid disorders, the rate of MG was highest in HT group (9.92/1,000 HT patients). There were four significant factors among four groups of thyroid disorders including age of onset of thyroid disease (p 0.004), MG classification (p<0.001), MG treatment (p<0.001), and thymic pathology (p 0.034). Among the four groups of thyroid disorders, patients with MG and HT were diagnosed with thyroid disease at the youngest age (27 years) compared with other thyroid diseases. Additionally, the MG patients with HT also had the highest proportion of MG class 4-5 a/b (7 patients, 43.75%), received prednisolone treatment (15 patients, 93.75%), received immunosuppressants (9 patients, 56.25%), received IVIG or PLEX (5 patients, 31.30%), and had thymoma (6 patients, 46.15%). CONCLUSION: MG is most prevalent in patients with HT. Patients with both MG and HT had more severe MG status and had higher rate of thymoma. Journal of the ASEAN Federation of Endocrine Societies 2019-11-10 2019 /pmc/articles/PMC7784156/ /pubmed/33442150 http://dx.doi.org/10.15605/jafes.034.02.05 Text en © 2019 Journal of the ASEAN Federation of Endocrine Societies https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.
spellingShingle Original Article
Virameteekul, Sasivimol
Charoensri, Suranut
Sawanyawisuth, Kittisak
Tiamkao, Somsak
Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title_full Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title_fullStr Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title_full_unstemmed Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title_short Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study
title_sort concurrence of myasthenia gravis and thyroid disorders: a retrospective database study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784156/
https://www.ncbi.nlm.nih.gov/pubmed/33442150
http://dx.doi.org/10.15605/jafes.034.02.05
work_keys_str_mv AT virameteekulsasivimol concurrenceofmyastheniagravisandthyroiddisordersaretrospectivedatabasestudy
AT charoensrisuranut concurrenceofmyastheniagravisandthyroiddisordersaretrospectivedatabasestudy
AT sawanyawisuthkittisak concurrenceofmyastheniagravisandthyroiddisordersaretrospectivedatabasestudy
AT tiamkaosomsak concurrenceofmyastheniagravisandthyroiddisordersaretrospectivedatabasestudy